<SEC-DOCUMENT>0001415889-24-019339-index.html : 20240708
<SEC-HEADER>0001415889-24-019339.hdr.sgml : 20240708
<ACCEPTANCE-DATETIME>20240708161511
ACCESSION NUMBER:		0001415889-24-019339
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20240703
FILED AS OF DATE:		20240708
DATE AS OF CHANGE:		20240708

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Brady Stephen R
		CENTRAL INDEX KEY:			0001606241
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35890
		FILM NUMBER:		241104886

	MAIL ADDRESS:	
		STREET 1:		C/O IMMUNE DESIGN CORP.
		STREET 2:		1616 EASTLAKE AVE. E, SUITE 310
		CITY:			SEATTLE
		STATE:			WA
		ZIP:			98102

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Tempest Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001544227
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				451472564
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		2000 SIERRA POINT PARKWAY
		STREET 2:		SUITE 400
		CITY:			BRISBANE
		STATE:			CA
		ZIP:			94005
		BUSINESS PHONE:		415-798-8589

	MAIL ADDRESS:	
		STREET 1:		2000 SIERRA POINT PARKWAY
		STREET 2:		SUITE 400
		CITY:			BRISBANE
		STATE:			CA
		ZIP:			94005

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Millendo Therapeutics, Inc.
		DATE OF NAME CHANGE:	20181207

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	OvaScience, Inc.
		DATE OF NAME CHANGE:	20120308
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>form4-07082024_040701.xml
<TEXT>
Document 1 - file: form4-07082024_040701.html

Document 1 - RAW XML: form4-07082024_040701.xml

</DOCUMENT>
</SEC-DOCUMENT>